Evidence map›Paper›PMID 28539385›Full record

ArticleOpen biology2017

Phosphatase UBLCP1 controls proteasome assembly.

Shuangwu Sun, Sisi Liu, Zhengmao Zhang, Wang Zeng, Chuang Sun, Tao Tao, Xia Lin, Xin-Hua Feng

Open access · goldAbstract read
In one paragraph

Article in Open biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Promoting proteostasis by cAMP/PKA and cGMP/PKG.Trends in molecular medicine · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Proteins containing ubiquitin-like (Ubl) domains not only bind to 26S proteasomes but also induce their activation.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  16. Reversible phosphorylation of Rpn1 regulates 26S proteasome assembly and function.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Shuangwu SunLife Sciences Institute and Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.ORCID 0000-0002-6220-1778
Sisi LiuLife Sciences Institute and Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
Zhengmao ZhangMichael E. DeBakey, Department of Surgery, Houston, TX, USA.
Wang ZengLife Sciences Institute and Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
Chuang SunMichael E. DeBakey, Department of Surgery, Houston, TX, USA.
Tao TaoState Key Laboratory of Stress Cell Biology, School of Life Sciences, Xiamen University, Xiamen, Fujian, People's Republic of China.
Xia LinMichael E. DeBakey, Department of Surgery, Houston, TX, USA.
Xin-Hua FengLife Sciences Institute and Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China xhfeng@zju.edu.cn xfeng@bcm.edu.ORCID 0000-0002-4418-0811
Michael E. DeBakey VA Medical Center · USZhejiang University · CNXiamen University · CN

Funding

Regulation of TGF-beta Receptor Signaling by HSP90R01GM063773 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI FENG, XIN-HUA · 2001 to 2010
$2.3M
Tumor Suppressor Function of Smad4 by UbiquitinR01CA108454 · NCI · BAYLOR COLLEGE OF MEDICINE · PI FENG, XIN-HUA · 2004 to 2010
$1.8M
Roles of Smad1 Dephosphorylation in Osteoblast DifferentiationR01AR053591 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI FENG, XIN-HUA · 2008 to 2012
$1.5M
ALK causes TGF-beta insensitivity in lung cancer cellsR21CA209007 · NCI · BAYLOR COLLEGE OF MEDICINE · PI FENG, XIN-HUA · 2016 to 2017
$379k
NCI NIH HHS R01 CA108454NCI NIH HHS R21 CA209007NIAMS NIH HHS R01 AR053591NIGMS NIH HHS R01 GM063773
6 · The paper itself

Abstract

Ubiquitin-like domain-containing C-terminal domain phosphatase 1 (UBLCP1), an FCP/SCP phosphatase family member, was identified as the first proteasome phosphatase. UBLCP1 binds to proteasome subunit Rpn1 and dephosphorylates the proteasome

Indexed as

Adenosine TriphosphatasesHEK293 CellsHeLa CellsHumansNuclear ProteinsPhosphoprotein PhosphatasesPhosphorylationProteasome Endopeptidase ComplexProtein BindingProtein Subunits26S proteasome non-ATPase regulatory subunit 13Adenosine TriphosphatasesNuclear ProteinsPhosphoprotein PhosphatasesProteasome Endopeptidase ComplexProtein SubunitsUBLCP1 protein, humanCTD phosphatasephosphorylationproteasomeUBLCP1

Identifiers

PMID28539385
PMCPMC5451543
OpenAlexW2618291208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.